Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition

Vaccine-Related Journal Articles

Hepatitis Prevention Settings: Harm reduction

Corrections Harm Reduction STD/HIV Clinic
Family Planning Perinatal  
Archive 2003-2000
Harm Reduction 2013 - 2009
Locations and Reasons for Initial Testing for Hepatitis C Infection — Chronic Hepatitis Cohort Study, United States, 2006–2010
Source: MMWR, August 16, 2013, Vol. 62(32):645-8
HTML
Predictors of HAV/HBV Vaccination Completion among Methadone Maintenance Clients
Authors: Nyamathi A, Sinha K, Greengold B, Cohen A, Marfisee M
Source: Res Nurs Health, February 8, 2010
Abstract
Assessment of a Hepatitis Educational Group for Veterans with Substance Use Disorders
Authors: Hagedorn H, Leighton T, Heim L
Source: Am J Drug Alcohol Abuse, January 2010, Vol. 36(1):57-60
Abstract
Hepatitis C Performance Measure on Hepatitis A and B Vaccination: Missed Opportunities?
Authors: Hernandez B, Hasson NK, Cheung R
Source: Am J Gastroenterol, June 2, 2009
Abstract
back to top
Harm Reduction 2008
Co-Infection of Hepatitis B and Hepatitis C Virus in Human Immunodeficiency Virus-Infected Patients in New York City, United States
Authors: Kim JH, Psevdos G, Suh J, Sharp VL
Source: World J Gastroenterol, November 21, 2008, Vol. 14(43):6689-93
Abstract
Injecting Drug Users' Understanding of Hepatitis C
Source: Addict Behav, July 22, 2008
Authors: O'Brien S, Day C, Black E, Dolan K
Abstract
Economic Evaluation of Delivering Hepatitis B Vaccine to Injection Drug Users
Authors: Hu Y, Grau LE, Scott G, Seal KH, Marshall PA, Singer M, Heimer R
Source: Am J Prev Med, July 2008, Vol. 35(1):25-32
Abstract
Prevalence and Correlates of Previous Hepatitis B Vaccination and Infection among Young Drug-Users in New York City
Authors: Amesty S, Ompad DC, Galea S, Fuller CM, Wu Y, Koblin B, Vlahov D
Source: J Community Health, June 2008, Vol. 33(3):139-48
Abstract
Greater Drug Injecting Risk for HIV, HBV, and HCV Infection in a City Where Syringe Exchange and Pharmacy Syringe Distribution Are Illegal
Source: J Urban Health, May 2008, Vol. 85(3):309-22
Authors: Neaigus A, Zhao M, Gyarmathy VA, Cisek L, Friedman SR, Baxter RC
Abstract
A Randomized Intervention Trial to Reduce the Lending of Used Injection Equipment Among Injection Drug Users Infected with Hepatitis C
Authors: Latka MH, Hagan H, Kapadia F, et al.
Source: Am J Public Health, May 2008, Vol. 98(5):853-61
Abstract
Prevalence of Hepatitis C Virus Infection Among Injection Drug Users in the United States, 1994-2004
Authors: Amon JJ, Garfein RS, Ahdieh-Grant L, et al.
Source: Clin Infect Dis, May 5, 2008
Abstract
Greater Drug Injecting Risk for HIV, HBV, and HCV Infection in a City Where Syringe Exchange and Pharmacy Syringe Distribution Are Illegal
Authors: Neaigus A, Zhao M, Gyarmathy VA, Cisek L, Friedman SR, Baxter RC
Source: J Urban Health, March 14, 2008
Abstract | HTML
Herbal Medicines in Acute Viral Hepatitis: A Ticket for More Trouble
Authors: Bernuau JR, Durand F
Source: Eur J Gastroenterol Hepatol, March 2008, Vol. 20(3): 161-3
Abstract
Hepatitis B Virus Infection and Immunization Status in a New Generation of Injection Drug Users in San Francisco
Authors: Lum PJ, Hahn JA, Shafer KP, Evans JL, Davidson PJ, Stein E, Moss AR
Source: J Viral Hepat, March 2008, Vol. 15(3):229-36
Abstract
back to top
Harm Reduction 2007
A Peer-Education Intervention to Reduce Injection Risk Behaviors for HIV and Hepatitis C Virus Infection in Young Injection Drug Users
Authors: Garfein RS, Golub ET, Greenberg AE, et al
Source: AIDS, Sep 21, 2007; 21(14):1923-1932
Abstract
Prevalence and Correlates of Hepatitis A among Adult Drug Users: The significance of incarceration and race/ethnicity
Authors: Latimer WW, Moleko AG, Melnikov A, et al
Source: Vaccine, August 13, 2007 [Epub ahead of print]
Abstract
Seroprevalence of Hepatitis C Virus and Hepatitis B Virus among San Francisco Injection Drug Users, 1998 to 2000
Authors: Tseng FC, Obrien, Zhang M, et al
Source: Hepatology July 26, 2007 [Epub ahead of print]
Abstract
Sex, Drugs, and Hepatitis C Virus
Author: Hahn JA
Source: J Infect Dis, June 1, 2007, Vol. 195(11):1556-9
Abstract
Individual and Couple-Level Risk Factors for Hepatitis C Infection among Heterosexual Drug Users: A Multilevel Dyadic Analysis
Authors: McMahon JM, Pouget ER, Tortu S
Source: J Infect Dis, June 1, 2007, Vol. 195(11):1572-81
Abstract
Hepatitis B Infection and Vaccination Among High-Risk Noninjection Drug-Using Women: Baseline data from the UNITY Study
Authors: Koblin BA, Xu G, Lucy , Robertson V, et al
Source: Sex Transm Dis. June 2007 (Epub)
Abstract
Methods to Recruit and Retain a Cohort of Young-Adult Injection Drug Users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT)
Authors: Garfein RS, Swartzendruber A, Ouellet LJ, Kapadia F, et al
Source: Drug Alcohol Depend. June 2007 (Epub)
Abstract
Integrating Hepatitis Prevention Services into a Substance Use Disorder Clinic
Authors: Hagedorn H. Dieperink E. Dingmann D, Durfee J, et al
Source: J Subst Abuse Treat. June 2007;32(4):391-8
Abstract
Benefits and Adverse Effects of Hepatitis C Screening: Early results of a screening program
Authors: Trepka MJ, Zhang G, Leguen F, Obiaja K, et al
Source: J Public Health Manag Pract. May/June, 2007;13(3):263-9
Abstract
Infectivity of Hepatitis C Virus in Plasma after Drying and Storing at Room Temperature
Authors: Kamili S, Krawczynski K, et al
Source: Infect Control Hosp Epidemiol, May 2007, Vol. 28(5):519-24
Abstract
A Systematic Review of Provider Knowledge of Hepatitis C: Is it Enough for a Complex Disease?
Authors: Zickmund SL, Brown KE, Bielefeldt K
Source: Dig Dis Sci. April 4, 2007 Apr 4 [EPub ahead of print]
Abstract
Sexual and Other Noninjection Risks for HBV and HCV Seroconversions Among Noninjecting Heroin Users
Authors: Neaigus A, Gyarmathy VA, Zhao M, Miller M, et al
Source: J Infect Dis. Apr 1, 2007;195(7):1052-61
Abstract
Self Reported Risk Behaviour Among Injecting Drug Users: Self versus assisted questionnaire completion
Authors: White B, Day C, Maher L
Source: AIDS Care, March 2007, Vol. 19(3):441-7
Abstract
Surveillance for Acute Viral Hepatitis--United States, 2005
Authors: Wasley A, Miller JT, Finelli L, Centers for Disease Control and Prevention
Source: MMWR Surveill Summ. March 16, 2007;56(3):1-24
HTML
Trends in Hepatitis B Virus, Hepatitis C Virus, and Human Immunodeficiency Virus Prevalence, Risk Behaviors, and Preventive Measures among Seattle Injection Drug Users Aged 18-30 Years, 1994-2004
Authors: Burt RD, Hagan H, Garfein RS, Sabin K, et al
Source: J Urban Health. Mar 14, 2007; [Epub ahead of print]
Abstract
Hepatitis C Management by Addiction Medicine Physicians: Results from a national survey
Authors: Litwin AH, Kunins HAV, Berg KM, Federman AD, et al
Source: J Subst Abuse Treat. March 2007;20; [Epub ahead of print]
Abstract
Injecting and Sexual Risk Correlates of HBV and HCV Seroprevalence Among New Drug Injectors
Authors: Neaigus A, Gyarmathy V, Miller M, Frajzyngier V, et al
Source: Drug Alcohol Depend Jul 10,;89(2-3):234-243. Epub 2007 Feb 7
Abstract
Convenience is the Key to Hepatitis A and B Vaccination Uptake among Young Adult Injection Drug Users
Authors: Campbell JV, Garfein RS, et al
Source: Drug Alcohol Depend, February 1, 2007
Abstract
back to top
Harm Reduction 2006
Hepatitis B Vaccination Coverage Among Adults --- United States, 2004
Source: MMWR, May 12, 2006, Vol. 55(18):509-511
HTML
Partner Notification for Persons with Chronic Hepatitis B Virus Infection: Use of a Syphilis Model Service
Source: Sexually Transmitted Diseases, May 2006, Vol. 33(5)
Abstract
Overcoming Barriers to Prevention, Care, and Treatment of Hepatitis C in Illicit Drug Users [Review] [131 refs]
Authors: Edlin BR, Kresina TF, Raymond DB, et al
Source: CID April 15, 2006, Vol. 40(5)276-85
Abstract
back to top
Harm Reduction 2005
Hepatitis C Virus Load and Survival Among Injection Drug Users in the United States
Source: Hepatology, December 2005, Vol. 42(6):1261-3
Abstract
Prevalence and Correlates of Hepatitis C Infection Among Users of North America’s First Medically Supervised Safer Injection Facility
Source: Public Health, December 2005, Vol. 119(12):1111-5
Abstract
Tattoos, Incarceration and Hepatitis B and C Among Street-Recruited Injection Drug Users in New Mexico, USA: Update
Source: Epidemiol Infect, December 2005, Vol. 133(6):1146-8
Abstract
Viral Evolution of Hepatitis C in Injection Drug Users
Source: J Viral Hepat, November 2005, Vol. 12(6):574-583
Abstract
Public Health Perspective on Vaccine-Preventable Hepatitis: Integrating Hepatitis A and B Vaccines into Public Health Settings
Source: Am J Med, October 2005, Vol. 118(Suppl 10A):100S-108S
Abstract
Health Disparities Among African-American and Hispanic Drug Injectors—HIV, AIDS, Hepatitis B Virus and Hepatitis C Virus: A Review
Source: AIDS, October 2005, Vol. 19(Suppl 3):S47-S52
Abstract
HIV/Hepatitis C Virus Co-Infection in Drug Users: Risk Behavior and Prevention
Source: AIDS, October 2005, Vol. 19(Suppl 3):S199-S207
Abstract
A Framework for Understanding Factors that Affect Access and Utilization of Treatment for Hepatitis C Virus Infection Among HCV-Mono-Infected and HIV/HCV-Co-Infected Injection Drug Users
Source: Aids, October 2005, Vol. 19(Suppl 3):S179-S189
Abstract
Reductions in Hepatitis C Virus and HIV Infections Among Injecting Drug Users in New York City, 1990-2001
Source: AIDS, October 2005, Vol. 19(Suppl 3):S20-5
Abstract
Psychological and Behavioral Differences among Drug Injector Who Use and Do Not Use Syringe Exchange Programs
Source: AIDS and Behavior, October 20, 2005, EPub
Abstract
Susceptibility to Hepatitis A in Patients with Chronic Liver Disease Due to Hepatitis C Virus Infection: Missed Opportunities for Vaccination
Source: Hepatology, September 2005, Vol. 42(3):688-695
Abstract
Risk Factors for Hepatitis B in an Outbreak of Hepatitis B and D Among Injection Drug Users
Source: Journal of Urban Health, September 2005, Vol. 82(3):468-78
Abstract
High Prevalence of Alcohol Use Among Hepatitis C Virus Antibody Positive Injection Drug Users in Three US Cities
Source: Drug Alcohol Depend, August 26, 2005:Epub
Abstract
Do Supervised Injecting Facilities Attract Higher-Risk Injection Drug Users?
Source: American Journal of Preventive Medicine, August 2005, Vol. 29(2):126-130
Abstract
Update: Syringe Exchange Programs—United States, 2002
Source: MMWR, July 15, 2005, Vol. 54(27):673-676
Abstract
Integrating Care for Hepatitis C Virus (HCV) and Primary Care for HIV for Injection Drug Users Coinfected with HIV and HCV
Source: Clin Infect Dis, July 1, 2005, Vol. 41(Suppl 1):S83-8
Abstract
Approaching Treatment for Hepatitis C Virus Infection in Substance Users
Source: Clin Infect Dis, July 1, 2005, Vol. 41(Suppl 1):S79-S82
Abstract
A Systematic Approach to the Treatment of HIV and Hepatitis C Virus Infection in the Inner City: A Canadian Perspective
Source: Clin Infect Dis, July 1, 2005, Vol. 41(Suppl 1):S73-8
Abstract
Coinfection with HIV and Hepatitis C Virus in Injection Drug Users and Minority Populations
Source: Clin Infect Dis, July 1, 2005, Vol. 41(Suppl 1):S7-S13
Abstract
Medical Management of HIV-Hepatitis C Virus Coinfection in Injection Drug Users
Source: Clin Infect Dis, July 1, 2005, Vol. 41(Suppl 1):S1-S6
Abstract
Management of Hepatitis C Virus in Special Populations: Patient and Treatment Considerations
Source: Clin Gastroenterol Hepatol, April 2005, Vol. 3(4):311-8
Abstract
Being Realistic About Benefits of Supervised Injecting Facilities
Source: The Lancet, March 26, 2005, Vol. 365(9465)
PDF
Circumstances Surrounding the First Injection Experience and their Association with Future Syringe Sharing Behaviors in Young Urban Drug Users
Source: Drug Alcohol Depend. March 7, 2005, Vol.77(3):303-9
Abstract
Adherence to Hepatitis B Virus Vaccination at Syringe Exchange Sites
Source: Journal of Urban Health, March 2005, Vol. 82(1):151-161
Abstract
Effects of an Intensive Street-Level Police Intervention on Syringe Exchange Program Use in Philadelphia, Pa.
Source: American Journal of Public Health, February 2005, Vol. 95(2):233-6
Abstract
Exploring the Role of Needle Selling in a Drug-Using Community in Baltimore, Maryland
Source: J Acquir Immune Defic Syndr, January 1, 2005, Vol. 38(1):57-60
Abstract
back to top
Harm Reduction 2004
Acceptance and Completion of Hepatitis B Vaccination Among Drug Users in New York City
Source: Communicable Disease and Public Health, December 2004, Vol. 7(4):294-300
Abstract
Co-occurring Hepatitis C, Substance Use, and Psychiatric Illness: Treatment Issues and Developing Integrated Models of Care
Source: Journal of Urban Health, December 2004, Vol.81(4):719-734
Abstract
Incidence of Hepatitis C Virus and HIV Among New Injecting Drug Users in London: Prospective Cohort Study
Source: British Medical Journal, November 12, 2004, Eprint 1-2
Abstract
A Comparison of Injection and Non-Injection Methamphetamine-Using HIV Positive Men Who Have Sex with Men
Source: Drug Alcohol Depend, November 11, 2004, Vol. 76(2):203-212
Abstract
Frequent Hepatitis C Virus Superinfection in Injection Drug Users
Source: Journal of Infectious Diseases, October 15, 2004, Vol. 190(8):1396-1403
Abstract
Correlates of Hepatitis C Virus Infections in Homeless Men: A Latent Variable Approach
Source: Drug Alcohol Depend, July 15, 2004, Vol. 75(1):89-95
Abstract
A Syringe Prescription Program to Prevent Infectious Disease and Improve Health of Injection Drug Users
Source: J Urban Health, March 2004, Vol. 81(1):122-134
Abstract
Hepatitis C Incidence--A Comparison Between Injection and Noninjection Drug Users in New York City
Source: Journal of Urban Health, March 2004, Vol. 81(1):20-4
Abstract
Poor Validity of Self-Reported Hepatitis B Virus Infection and Vaccination Status Among Young Drug Users
Source: Clinical Infectious Diseases, February 15, 2004, Vol. 38(4):587-590
Abstract
Hepatitis B Virus Infection and Vaccination Among Young Injection and Non-Injection Drug Users: Missed Opportunities to Prevent Infection
Source: Drug & Alcohol Dependence, January 7, 2004, Vol. 73(1):69-78
Abstract
The Massachusetts HIV, Hepatitis, Addiction Services Integration (HHASI) Experience: Responding to the Comprehensive Needs of Individuals with Co-Occurring Risks and Conditions
Source: Public Health Reports, January/February 2004, Vol. 119(1):25-31
HTML
back to top
Harm Reduction Archive
Harm reduction journal articles 2003-2000
Immunization Action Coalition  •  2550 University Avenue West  •  Suite 415 North  •  Saint Paul, Minnesota  •  55114
tel 651-647-9009  •  fax 651-647-9131
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.